"10.1371_journal.pone.0135441","plos one","2015-08-18T00:00:00Z","Diego Bertoli; Federico Serana; Alessandra Sottini; Cinzia Cordioli; Davide Maimone; Maria Pia Amato; Diego Centonze; Ciro Florio; Elisa Puma; Ruggero Capra; Luisa Imberti","CREA, Diagnostics Department, Spedali Civili of Brescia, Brescia, Italy; Multiple Sclerosis Center, Spedali Civili of Brescia, Presidio di Montichiari, Brescia, Italy; Department of Neurology, Garibaldi Hospital, Catania, Italy; Department of Neurology, University of Florenceâ€Careggi Hospital, Florence, Italy; Department of Neurosciences Tor Vergata University, S. Lucia Foundation IRCCS, Rome, Italy; Department of Neurology, Ospedale Caldarelli, Napoli, Italy; Biogen Italy, Medical Department, Milan, Italy","Conceived and designed the experiments: LI RC AS. Performed the experiments: DB AS. Analyzed the data: FS CC DB. Contributed reagents/materials/analysis tools: CC DM MPA DC CF RC EP. Wrote the paper: DB FS LI RC. Revised the manuscript: EP.","The authors have read the journals policy and the authors of this manuscript have the following competing interests: FS received support to cover travel expenses and participation to congresses from Biogen, Merck-Serono, TEVA. LI received support to cover travel expenses and participation to congresses from Biogen, Merck-Serono, TEVA, and grants from Biogen and Merck-Serono. RC is a member of Steering Committee in clinical trials for Novartis and Biogen and received honoraria for speaking from Biogen, Genzyme, Novartis, Sanofi Aventis and TEVA. CC received honoraria from Biogen, Genzyme and Novartis. DM received speaker honoraria or travel grants from Bayer Healthcare, Biogen, Merck Serono, Novartis, Sanofi Aventis, and Teva. MPA serves on scientific advisory boards for Biogen, Bayer Schering Pharma, Merck Serono, Novartis, Sanofi Aventis, Almirall and Genzyme and receives speaker honoraria and research support from Biogen, Merck Serono, Bayer Schering Pharma, Novartis, Almirall and Genzyme. DC is an Advisory Board member of Bayer Schering, Biogen, Merck-Serono, Teva and received honoraria for speaking or consultation fees from Almirall, Bayer Schering, Biogen, Genzyme, GW Pharmaceuticals, Merck Serono, Novartis, Sanofi-Aventis, Teva. He is also an external expert consultant of the European Medicine Agency (EMA), and the principal investigator in clinical trials for Bayer Schering, Biogen, Novartis, Merck Serono, Sanofi-Aventis, Teva. CF received honoraria from Biogen, Bayer Schering Pharma, Merck Serono, Novartis and Sanofi-Aventis. EP is an employee of Biogen Italy. DB and AS report no competing interests. This does not alter the authors adherence to PLOS ONE policies on sharing data and materials.","2015","08","Diego Bertoli","DB",11,FALSE,3,2,3,4,TRUE,TRUE,FALSE,0,NA,FALSE
